Proposed Registration Decision PRD2026-07, AQUABAC II XT Biological Larvicide, containing Bacillus thuringiensis subsp. Israelensis serotype H-14, strain BMP-144April 22, 2026
Share Facebook Twitter LinkedIn Pinterest Email Zambia Launches a Nationwide Polio Vaccination Campaign to Protect Every Child Under Five serisk@who.int Tue, 21/04/2026 – 14:56 21 April 2026…Read More
Trusting science to protect tomorrow’s health: An interview with Professor Francine Ntoumi (Congo)April 22, 2026
Tanzania strengthens environmental surveillance to detect and prevent health risks with new pollution surveillance systemsApril 21, 2026